Abstract
An activity in serum which inhibits reactive lysis has recently been shown to do so by preventing the attachment of C567 complexes to cells, and hence has been designated C567-INH. This report describes certain physiochemical characteristics of the inhibitory activity. It behaves as a heat-stable pseudoglobulin, soluble in 20 per cent Na2SO4, and having alpha1 mobility on Pevikon block electrophoresis. It is excluded from CM cellulose at pH 6-0, RSC Equals 0.007 M, is retained by an XM-100 membrane and is heterogenous on Sephadex G-200, eluting in at least two peaks. The combined active materials from the Sephadex column elute from DE-52 in at least four peaks. The mechanism of action of material from each of these four peaks is shown to involve prevention of attachment of C567 complexes to membranes, and this is shown to involve an effect on C567 complexes in solution rather than an effect on the membrane. A less dramatic effect on the lysis of EC567 by limited quanities of C8 and C9 can be demonstrated. Haemolytic studies using cell-bound C567 suggest that the interaction of C567-INH with C567 involves a loose reversible association. It is therefore postulated that C567-INH inhibits reactive lysis primarily by reversibly associating with the nascent C567 complex in solution, increasing its bulk and decreasing its diffusion capacity so that it is unable to reach a cell membrane before its haemolytic potential decays.
MeSH Terms
Animals
Cell Membrane
Chemical Phenomena
Chemistry
Chromatography
Chromatography, DEAE-Cellulose
Chromatography, Gel
Complement System Proteins
Electrophoresis
Guinea Pigs/immunology
Hemolysis
Hot Temperature
Humans
Models, Biological
Protein Binding
Serum Globulins/immunology
Sheep/immunology
Solubility
Time Factors
Ultrafiltration
Chemicals
Serum Globulins
Complement System Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
McLeod B
Baker P
Gewurz H
References (12)
12 references, click to expand
-
Chemotactic factor inactivator in normal human serum.
J Clin Invest. 1973 May;52(5):1200-6
PMID: 4121701
-
The alternate complement pathway in cell damage: antibody-mediated cytolysis of erythrocytes and nucleated cells.
J Immunol. 1972 Sep;109(3):595-601
PMID: 4115545
-
Studies on the inhibition of C56 initiated lysis (reactive lysis). I. Description of the phenomenon and methods of assay.
Immunology. 1974 Jun;26(6):1145-57
PMID: 4137213
-
Studies on the mode of action of the fifth, sixth and seventh component of human complement in immune haemolysis.
Immunology. 1967 Jul;13(1):101-17
PMID: 4165629
-
Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.
J Exp Med. 1970 Apr 1;131(4):643-57
PMID: 4193935
-
Lysis of erythrocytes by complement in the absence of antibody.
J Exp Med. 1970 Nov;132(5):898-915
PMID: 5470509
-
Interactions between human C5, C6, and C7 and their functional significance in complement-dependent cytolysis.
J Immunol. 1973 Aug;111(2):536-45
PMID: 4268733
-
Reaction mechanisms of nascent C567 (reactive lysis). I. Reaction characteristics for production of EC567 and lysis by C8 and C9.
J Immunol. 1972 Aug;109(2):353-9
PMID: 4558539
-
The membrane attack mechanism of complement. Reversible interactions among the five native components in free solution.
J Exp Med. 1973 Aug 1;138(2):428-37
PMID: 4737061
-
Blocking of the hemolytic expression of the classical complement sequence by products of complement activation via the alternate pathway. Materials responsible for the blocking phenomenon and their proposed mechanism of action.
J Immunol. 1973 Feb;110(2):390-400
PMID: 4684033
-
Molecular analysis of the membrane attack mechanism of complement.
J Exp Med. 1972 Mar 1;135(3):549-66
PMID: 5058233
-
Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.
J Exp Med. 1970 Apr 1;131(4):629-41
PMID: 4193934